Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

Skin emollient and early complementary feeding to prevent infant atopic dermatitis (PreventADALL): a factorial, multicentre, cluster-randomised trial.

Skjerven HO, Rehbinder EM, Vettukattil R, LeBlanc M, Granum B, Haugen G, Hedlin G, Landrø L, Marsland BJ, Rudi K, Sjøborg KD, Söderhäll C, Staff AC, Carlsen KH, Asarnoj A, Bains KES, Carlsen OCL, Endre KMA, Granlund PA, Hermansen JU, Gudmundsdóttir HK, Hilde K, Håland G, Kreyberg I, Olsen IC, Mägi CO, Nordhagen LS, Saunders CM, Skrindo I, Tedner SG, Værnesbranden MR, Wiik J, Jonassen CM, Nordlund B, Carlsen KCL.

Lancet. 2020 Mar 21;395(10228):951-961. doi: 10.1016/S0140-6736(19)32983-6. Epub 2020 Feb 19. Erratum in: Lancet. 2020 Mar 21;395(10228):e53.

PMID:
32087121
2.

Food and nutrient intake and adherence to dietary recommendations during pregnancy: a Nordic mother-child population-based cohort.

Saunders CM, Rehbinder EM, Carlsen KCL, Gudbrandsgard M, Carlsen KH, Haugen G, Hedlin G, Jonassen CM, Sjøborg KD, Landrø L, Nordlund B, Rudi K, O Skjerven H, Söderhäll C, Staff AC, Vettukattil R, Carlsen MH.

Food Nutr Res. 2019 Dec 20;63. doi: 10.29219/fnr.v63.3676. eCollection 2019.

3.

Snus in pregnancy and infant birth size: a mother-child birth cohort study.

Kreyberg I, Hilde K, Bains KES, Carlsen KH, Granum B, Haugen G, Hedlin G, Jonassen CM, Nordhagen LS, Nordlund B, Rueegg CS, Sjøborg KD, Skjerven HO, Staff AC, Vettukattil R, Lødrup Carlsen KC; PreventADALL Study Group.

ERJ Open Res. 2019 Dec 2;5(4). pii: 00255-2019. doi: 10.1183/23120541.00255-2019. eCollection 2019 Oct.

4.

Stopping when knowing: use of snus and nicotine during pregnancy in Scandinavia.

Kreyberg I, Bains KES, Carlsen KH, Granum B, Gudmundsdóttir HK, Haugen G, Hedlin G, Hilde K, Jonassen CM, Nordhagen LS, Nordlund B, Sjøborg KD, Skjerven HO, Staff AC, Söderhäll C, Vettukatil RM, Lødrup Carlsen KC.

ERJ Open Res. 2019 Apr 8;5(2). pii: 00197-2018. doi: 10.1183/23120541.00197-2018. eCollection 2019 Apr. Erratum in: ERJ Open Res. 2020 Feb 17;6(1):.

5.

Safety and acceptability of human papillomavirus testing of self-collected specimens: A methodologic study of the impact of collection devices and HPV assays on sensitivity for cervical cancer and high-grade lesions.

Leinonen MK, Schee K, Jonassen CM, Lie AK, Nystrand CF, Rangberg A, Furre IE, Johansson MJ, Tropé A, Sjøborg KD, Castle PE, Nygård M.

J Clin Virol. 2018 Feb - Mar;99-100:22-30. doi: 10.1016/j.jcv.2017.12.008. Epub 2017 Dec 21.

6.

Cytology and human papillomavirus testing 6 to 12 months after ASCUS or LSIL cytology in organized screening to predict high-grade cervical neoplasia between screening rounds.

Tropé A, Sjøborg KD, Nygård M, Røysland K, Campbell S, Alfsen GC, Jonassen CM.

J Clin Microbiol. 2012 Jun;50(6):1927-35. doi: 10.1128/JCM.00265-12. Epub 2012 Apr 18.

7.

Role of high-risk human papillomavirus (HPV) mRNA testing in the prediction of residual disease after conisation for high-grade cervical intraepithelial neoplasia.

Tropé A, Jonassen CM, Sjøborg KD, Nygård M, Dahl FA, Alfsen GC, Lie AK.

Gynecol Oncol. 2011 Nov;123(2):257-62. doi: 10.1016/j.ygyno.2011.07.032. Epub 2011 Aug 12.

PMID:
21839500
8.

Vaccination against human papillomavirus--an impact on preterm delivery? Estimations based on literature review.

Sjøborg KD, Eskild A.

Acta Obstet Gynecol Scand. 2009;88(3):255-60. doi: 10.1080/00016340802699100. Review.

PMID:
19172417
9.

Pregnancy outcome after cervical cone excision: a case-control study.

Sjøborg KD, Vistad I, Myhr SS, Svenningsen R, Herzog C, Kloster-Jensen A, Nygård G, Hole S, Tanbo T.

Acta Obstet Gynecol Scand. 2007;86(4):423-8.

PMID:
17486463

Supplemental Content

Loading ...
Support Center